Strategies for Interdisciplinary Human Gene Editing Research: Insights from a Swiss Project
- PMID: 40173337
- PMCID: PMC7617730
- DOI: 10.1089/crispr.2024.0041
Strategies for Interdisciplinary Human Gene Editing Research: Insights from a Swiss Project
Abstract
CRISPR gene editing is a cutting-edge technology that has advanced tremendously in recent years. The first clinical CRISPR applications have been approved, and more gene editing therapies are to be expected in human medicine. Consequently, continuous basic research is needed to assess possibilities and prime future clinical applications. Because this technology not only offers new possibilities for treating diseases but also raises important ethical and societal questions, collaboration between human, life, biomedical, and medical sciences is needed. In this article, we discuss the practical challenges of such interdisciplinary projects and present strategies for addressing them based on our experience of conducting an interdisciplinary project on CRISPR. This work aims to help and encourage interdisciplinary collaborations and discussions on modern scientific endeavors that, such as gene editing, tend to blur the lines between traditional disciplines. The strategies suggested include realistic expectations, shared goals, space setting, and expert and lay dialogue.
Figures

References
-
- Wang JY, Doudna JA. CRISPR technology: A decade of genome editing is only the beginning. Science. 2023;379(6629):251. - PubMed
-
- Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1077. - PubMed
-
- U.S. Food and Drug Administration. FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease. 2023. [Last accessed: Aug 20, 2024]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-g....
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources